MedTrace Logo

Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer

NCT01362582 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2014-09-25

No results posted yet for this study

Summary

A randomised multicentre clinical phase IIIb trial for patients suffering from pancreatic adenocarcinoma receiving defined second or higher line chemotherapy and additionally parenteral nutrition (study arm A) or best supportive nutritional care (study arm B).

Conditions

Interventions

DRUG

SMOF Kabiven

SMOFKabiven® will be given over night with a content of 1100 kcal in 986 ml.

Sponsors & Collaborators

  • Heidelberg University

    collaborator OTHER

  • National Center for Tumor Diseases, Heidelberg

    lead OTHER

Principal Investigators

  • Dirk Jäger, Prof. Dr. · University of Heidelberg / National Center for Tumordiseases

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2014-08-31
Completion
2014-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01362582 on ClinicalTrials.gov